Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;32(4):374-8.
doi: 10.1055/s-0035-1564792.

Venous Thromboembolic Disease: The Use of the Aspiration Thrombectomy Device AngioVac

George Behrens  1 , Haraldur Bjarnason  2
Affiliations
Review

Venous Thromboembolic Disease: The Use of the Aspiration Thrombectomy Device AngioVac

George Behrens et al. Semin Intervent Radiol. 2015 Dec.

Abstract

Central venous thrombosis is a complex problem, particularly in cases where the thrombus burden is large. Several interventional techniques and devices have been developed over the past 15 to 20 years to manage this entity, but the vast majority of them still need the concomitant use of thrombolytics to achieve an optimal result. AngioVac (AngioDynamics, Latham, NY) is the first aspiration thrombectomy device capable to remove a larger burden of undesired intravascular material such as thrombus, tumor, and foreign bodies without the need of lytics. This review focuses on the AngioVac device in the management of iliocaval thrombosis and pulmonary embolism.

Keywords: IVC thrombosis; interventional radiology; pulmonary embolism; thrombolysis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic representing the AngioVac system (AngioDynamics, Latham, NY) and its setup.
Fig. 2
Fig. 2
AngioVac cannula tip (AngioDynamics, Latham, NY). (a) 20 degree angle tip which aids in navigation and allows some steerability. (b) Straight tip presentation.
Fig. 3
Fig. 3
Representative case of a patient with significant inferior vena cava (IVC) thrombosis. (a) Venography of the IVC preintervention demonstrates severe IVC thrombosis (arrow); the AngioVac device is in position for aspiration of the clot (arrowhead). (b) Venography demonstrates near-complete removal of the occlusive clot. The AngioVac device (AngioDynamics, Latham, NY) is again noted (arrowhead).
See this image and copyright information in PMC

References

    1. Parikh S, Motarjeme A, McNamara T. et al.Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience. J Vasc Interv Radiol. 2008;19(4):521–528. - PubMed
    1. Vedantham S, Vesely T M, Sicard G A. et al.Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol. 2004;15(6):565–574. - PubMed
    1. Lin P H, Zhou W, Dardik A. et al.Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg. 2006;192(6):782–788. - PubMed
    1. Arko F R Davis C M III Murphy E H et al.Aggressive percutaneous mechanical thrombectomy of deep venous thrombosis: early clinical results Arch Surg 20071426513–518., discussion 518–519 - PubMed
    1. Kim H S, Patra A, Paxton B E, Khan J, Streiff M B. Catheter-directed thrombolysis with percutaneous rheolytic thrombectomy versus thrombolysis alone in upper and lower extremity deep vein thrombosis. Cardiovasc Intervent Radiol. 2006;29(6):1003–1007. - PubMed